Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History GLPG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics GLPG

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Galapagos NV ADR

GLPG
Current price
28.49 USD -0.03 USD (-0.11%)
Last closed 28.83 USD
ISIN US36315X1019
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 899 813 376 USD
Yield for 12 month +10.81 %
1Y
3Y
5Y
10Y
15Y
GLPG
21.11.2021 - 28.11.2021

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium. Address: Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

29.14 USD

P/E Ratio

Dividend Yield

Financials GLPG

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures GLPG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+324 340 638 USD

Last Year

+282 069 716 USD

Current Quarter

+88 221 209 USD

Last Quarter

+88 830 710 USD

Current Year

-111 396 382 USD

Last Year

+239 723 489 USD

Current Quarter

+72 067 069 USD

Last Quarter

-44 045 301 USD
EBITDA -276 281 760 USD
Operating Margin TTM -211.68 %
Price to Earnings
Return On Assets TTM -4.66 %
PEG Ratio
Return On Equity TTM -6.36 %
Wall Street Target Price 29.14 USD
Revenue TTM 288 193 984 USD
Book Value 41.74 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 20.10 %
Dividend Yield
Gross Profit TTM 131 012 000 USD
Earnings per share -3.22 USD
Diluted Eps TTM -3.22 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 74.80 %
Profit Margin -58.83 %

Stock Valuation GLPG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 166.67
Enterprise Value Revenue 1.18
Price Sales TTM 6.59
Enterprise Value EBITDA -31.50
Price Book MRQ 0.58

Technical Indicators GLPG

For 52 Weeks

22.36 USD 31.23 USD
50 Day MA 27.69 USD
Shares Short Prior Month 1 452 385
200 Day MA 26.87 USD
Short Ratio 3.71
Shares Short 1 467 628
Short Percent 3.49 %